Category Archives: Drug Side Effects

Fibromyalgia Chronic Fatigue Immunocal By: Jorge immunocal … Continue reading →

New York, NY (PRWEB) March 28, 2013 The prescription drug resource center DrugRisk.com is announcing new information to the site for those who have taken the medication Actos for diabetes. With drug maker Takeda facing claims from patients alleging bladder cancer, the first trial is underway in California. The goal of DrugRisk is to improve the safety of patients taking popular prescription drugs by providing the most up-to-date warnings, recalls, studies and legal news. Visitors can determine if others have experienced similar side effects and decide if they need legal advice. The resource center contains warnings from experts such as the FDA and European Medicines Agency*, who have warned that long-term use of Actos may be associated with an increased bladder cancer risk. The drug has also been banned in France and Germany**. Although Actos remains on the market in the United States, DrugRisk has learned that as many as 3,000 patients have filed an Actos lawsuit against drug maker Takeda Pharmaceuticals alleging they developed bladder cancer***. Over 1,200 of these have been consolidated in a special multi-district federal court in Louisiana, while others are pending in California. The resource center has added information from the first of these Actos … Continue reading →

http://www.DrugRisks.com is the most helpful resource on the web for prescription medication alerts, side effects and legal news. Visit us today Chicago, IL (PRWEB) March 29, 2013 DrugRisks was created to provide those using popular medication devices, such as IUD contraceptives, with the latest safety alerts, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice. The resource center has added information showing the FDA has received over 47,000 AERS adverse event reports among patients using Mirena IUDs*. Of those, 5079 involved dislocation and 1421 involved device migration, which can damage the uterine wall or nearby organs*. Over 6% of patients required hospitalization or surgery. DrugRisks recently added a case study by the American Journal of Obstetrics and Gynecology which cautions of risks for women who must undergo surgery to remove an IUD like Mirena after the devices dislodge and perforate into the abdominal cavity**. Due to the growing number of patients filing a Mirena lawsuit, lawyers recently requested that cases be consolidated to one federal Multi-District Litigation court in Ohio***. The petition estimates that, with more than 2 million users, hundreds of Mirena perforation cases could … Continue reading →

Drug side effects and bioresonance (greek subtitles) By: Pi; epsilon; rho; iota; kappa; lambda;ή sigmaf; Delta; iota; delta; alpha; sigma; kappa;ά lambda; omicron; upsilon; … Continue reading →

Particles of the hepatitis C virus are imaged with an electron microscope. Particles of the hepatitis C virus are imaged with an electron microscope. With an estimated 2 million baby boomers infected with hepatitis C, the disease has reached epidemic levels among Americans age 48 to 68. Doctors can now cure about 70 percent of hepatitis C cases, but the drugs' side effects can be severe. And many Americans are still left with a disease that can cause liver failure and cancer. So doctors have been desperate for better treatment options. One of the drugs in the pipeline, called miravirsen, may be able to stop the virus with little side effects, doctors from University Health Network in Toronto, Canada, reported Wednesday. Their findings, published in The New England Journal of Medicine, are preliminary the doctors gave the drug to just 27 patients for about a month. (Another 9 patients in the study were given a placebo.) But the study is still drawing attention because it offers proof-of-concept for a whole new class of drugs, called RNA interference drugs. RNAi drugs work differently than traditional antivirals and antibiotics. And some scientists think they may have the potential to treat many illnesses, … Continue reading →

A recent study says that diabetes drug Byetta, manufactured by Amylin Pharmaceutical in conjunction with Eli Lilly and Company, could cause damage to the pancreaseven cancer. The Rottenstein Law Group, which is accepting clients in Byetta lawsuits, maintains a Byetta Legal Information Center on its website designed to provide more information on Byetta side effects and lawsuits. New York, NY (PRWEB) March 25, 2013 The UCLA study showed increased evidence of pre-cancerous cellular changes associated with Type 2 diabetes treatments, according to Bloomberg. The increase in changes topped 40 percent. In 2007, two years after Byetta went to market, the U.S. Food and Drug Administration said it had received many reports of pancreatitis from Byetta users, the article said. The FDA recently issued a report** indicating it was evaluating the Byetta side effects claims of unpublished research studies. Rochelle Rottenstein, principal of the Rottenstein Law Group, said that the growing body of evidence*** of Byettas alleged pancreatic side effects means that patients should be vigilant about their rights. Patients trust drug companies to produce helpfulnot potentially harmfulmedications, Rottenstein said. It is important that patients understand that if they believe they have been harmed there are advocates available to help them … Continue reading →

Thunder Killer Strain Imported line. By: Glenn Turgano … Continue reading →

BOSTON--(BUSINESS WIRE)-- Leading pharmacy Law plaintiffs law firm, Gilman Law, LLP is representing individuals in product liability claims involving drug side effects and dangerous medical devices, and is alerting consumers to recent and impending Supreme Court decisions that greatly affect their rights to pursue compensation for any injuries caused by generic drug side effects. In 2011, the Supreme Court ruled in Pliva vs. Mensing that federal law pre-empts any state laws that impose a duty on generic drug makers to warn the public of dangerous side effects associated with their products. The effect of the decision has been to bar and prevent victims of generic drug injuries from pursuing failure-to-warn against generic drug manufacturers, or to recover any monetary compensation regardless of the merits of such a claim. (Pliva v. Mensing, 131 S. Ct. 2567 (2011)) If you or a loved one were injured by these or any other medical product, please call Gilman Law LLP Toll-FREE a 1-888-252-0048 for your free, no-obligation legal consultation, or visit the firms website at http://www.gilmanlawllp.com. On March 18th, the Supreme Court heard oral arguments in Bartlett vs. Mutual Pharm. Co., Inc., another generic drug case. Depending on the Courts decision in Bartlett, consumers … Continue reading →

Contributor (866) 529-2400 Studies in Japan and in Norway may contribute to the body of analysis of Mirena side effects. Bayers Mirena intrauterine device has been the subject of lawsuits in which plaintiffs have reported one or more severe adverse reactions, including: Approved by the U.S. Food and Drug Administration in 2000, the Mirena IUD is inserted by a health care professional for pregnancy prevention. The FDA in 2009 broadened the indications of this levonorgestrel intrauterine system to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention. The U.S. National Institutes of Health as of this writing had not posted the results of a Bayer-sponsored observational study in Japan that tracked from 2007 to 2012 550 Mirena IUD patients. One of the studys goals was to observe the incidence of adverse drug reactions, especially pelvic inflammatory disease, in women who are inserted Mirena. Additionally, a segment of the scientific and regulatory communities await the results of a study sponsored by the University Hospital of North Norway in which 200 patients with low risk endometrial hyperplasia ages 30 to 70 will receive one of three treatments. The Mirena IUD is one of them. The … Continue reading →

Dallas, Texas (PRWEB) March 21, 2013 The birth control safety advocates at DrugRisk.com are alerting women whove used the vaginal ring contraceptive NuvaRing of updated legal news added to the site - the federal court where more than 1,000 NuvaRing injury claims await litigation has delayed the start of trials until October. DrugRisk was created with the goal of improving patient safety through clear information. By providing the latest drug alerts, research, legal news and recalls, patients can see if others are experiencing similar side effects and decide if they need legal advice, explains DrugRisk representative Ryan Mayer. Health experts have linked contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots*. DrugRisk has also compiled the latest figures from the FDA, which show more than 5,300 adverse reports have been filed among women using NuvaRing devices.** The most common side effects were 1,177 occurrences of pulmonary embolism and 1,155 reports of thrombosis or deep vein thrombosis. Over 30% of cases resulted in hospitalization while 3% ended in death**. … Continue reading →